Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group - Concepedia

Concepedia

Publication | Open Access

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

DOI Full Paper Access

60

Citations

38

References

2013

Year

Lisa Pleyer, Reinhard Stauder, Sonja Burgstaller, Martin Schreder, Christoph Tinchon, Michael Pfeilstöcker, Susanne Steinkirchner, Thomas Melchardt, Martina Mitrovic, Michael Girschikofsky,

Journal of Hematology & Oncology

Abstract

In this large cohort of AML-patients treated with azacitidine, age >80 years, number of comorbidities and/or BM-blasts >30% did not adversely impact OS.

References

	Year	Citations

Page 1